Search

everythinglearnresearchcommunity

for

Search:↓

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

PP405 may help hair growth by activating hair follicle stem cells.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Heparin-functionalized nanofabrics help heal wounds effectively and safely without scars in 14 days.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

FGF signaling is crucial for starting feather development in chicken embryos.

Antibody treatments show promise for hair loss but need more research.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Ginsenoside Rg3 from Panax ginseng can lighten skin by reducing melanin production.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Suppressing the HGPS mutation may improve symptoms and suggest reversibility.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

iL-PRF treatment improves hair growth for androgenetic alopecia.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

New ginseng compounds may help treat degenerative diseases.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Platelet-rich plasma may successfully treat lichen planopillaris, as shown by one patient's symptom regression.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

QLT0267 stops hair follicle cell growth and movement.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.